文献速递系统性红斑狼疮

足细胞NLRP3炎症小体激活参与狼疮肾炎蛋白尿发生

Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis.
PubMed 文献 · Arthritis Rheumatol · 2017-06-26

该研究在狼疮倾向NZM2328小鼠及狼疮肾炎患者肾活检组织中检测到足细胞NLRP3炎症小体激活,使用NLRP3选择性抑制剂MCC950治疗NZM2328小鼠可改善蛋白尿、肾脏组织学病变及足细胞足突融合。体外实验显示,患病NZM2328小鼠血清通过活性氧产生激活足细胞系NLRP3炎症小体。

要点

  • 狼疮倾向小鼠和狼疮肾炎患者足细胞中NLRP3炎症小体均被激活。
  • MCC950抑制NLRP3可改善狼疮倾向小鼠蛋白尿、肾脏组织学病变及足细胞足突融合。
  • 患病NZM2328小鼠血清通过活性氧产生激活足细胞系NLRP3炎症小体。

核心结论

  • 足细胞NLRP3炎症小体在狼疮倾向小鼠和狼疮肾炎患者中均被激活。
  • NLRP3激活参与狼疮肾炎足细胞损伤及蛋白尿发生的发病机制。

研究设计与样本

  • 研究使用荧光标记的caspase 1抑制剂探针检测狼疮倾向NZM2328小鼠及狼疮肾炎患者肾活检组织足细胞中NLRP3炎症小体激活。
  • 使用NLRP3选择性抑制剂MCC950治疗NZM2328小鼠,评估蛋白尿、足细胞超微结构及肾脏病理。
  • 体外用患病NZM2328小鼠血清刺激足细胞系,并通过流式细胞术分析细胞。

主要发现

  • 狼疮倾向小鼠和狼疮肾炎患者足细胞中NLRP3炎症小体被激活。
  • MCC950抑制NLRP3可改善狼疮倾向小鼠的蛋白尿、肾脏组织学病变及足细胞足突融合。
  • 患病NZM2328小鼠血清通过活性氧产生激活足细胞系NLRP3炎症小体。

临床怎么用

  • NLRP3炎症小体激活可作为狼疮肾炎足细胞损伤及蛋白尿的潜在机制关注点。
  • NLRP3选择性抑制剂MCC950在狼疮倾向小鼠中显示改善蛋白尿和肾脏病变的作用,但尚未提供人体用药证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Development of proteinuria in lupus nephritis (LN) is associated with podocyte dysfunction. The NLRP3 inflammasome has been implicated in the pathogenesis of LN. The purpose of this study was to investigate whether NLRP3 inflammasome activation is involved in the development of podocyte injury in LN. METHODS: A fluorescence-labeled caspase 1 inhibitor probe was used to detect the activation of NLRP3 inflammasomes in podocytes derived from lupus-prone NZM2328 mice and from renal biopsy tissues obtained from patients with LN. MCC950, a selective inhibitor of NLRP3, was used to treat NZM2328 mice. Proteinuria, podocyte ultrastructure, and renal pathology were evaluated. In vitro, sera from diseased NZM2328 mice were used to stimulate a podocyte cell line, and the cells were analyzed by flow cytometry. RESULTS: NLRP3 inflammasomes were activated in podocytes from lupus-prone mice and from patients with LN. Inhibition of NLRP3 with MCC950 ameliorated proteinuria, renal histologic lesions, and podocyte foot process effacement in lupus-prone mice. In vitro, sera from diseased NZM2328 mice activated NLRP3 inflammasomes in the podocyte cell line through the production of reactive oxygen species. CONCLUSION: NLRP3 inflammasomes were activated in podocytes from lupus-prone mice and from LN patients. Activation of NLRP3 is involved in the pathogenesis of podocyte injuries and the development of proteinuria in LN.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Fu R, Guo C, Wang S, et al. Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis. Arthritis Rheumatol. 2017. PMID: 28544564. doi:10.1002/art.40155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。